Status:
COMPLETED
Efficacy of Nasojejunal Enteral Feeding in Critically Ill Patients.
Lead Sponsor:
Melbourne Health
Conditions:
Critically Ill
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine if naso-jejunal feeding (feeding beyond the stomach) improves the efficacy of enteral feeding (feeding into the gut) in critically ill patients. The study hy...
Detailed Description
The study examines the area of enteral feeding in critically ill patients. Current standard enteral feeding practice is via a nasogastric with the addition of promotility agents for patients who fail ...
Eligibility Criteria
Inclusion
- Adult patients (18years or over) admitted to the ICU with an expected stay of more than 48 hours.
- Patients commenced on enteral feeding via a nasogastric tube who fail to tolerate gastric feeding due to excessive gastric aspirate volumes.
- Patients who consent or if the patient is incompetent, the next of kin, who consent, to inclusion in the study.
- \-
Exclusion
- patients less than 18 years of age.
- Patients with known allergy to promotility agents, metoclopramide or erythromycin.
- Patients with a contra indication to nasojejunal feeding. -
Key Trial Info
Start Date :
May 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2005
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00256048
Start Date
May 1 2003
End Date
July 1 2005
Last Update
April 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Intensive Care Unit, Royal Melbourne Hospital, Grattan Street
Parkville, Victoria, Australia, 3050